Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 16, 2016
[ Fri, Dec 16th 2016
] - WOPRAI
[ Fri, Dec 16th 2016
] - WOPRAI
[ Fri, Dec 16th 2016
] - WOPRAI
[ Fri, Dec 16th 2016
] - WOPRAI
[ Fri, Dec 16th 2016
] - WOPRAI
Thu, December 15, 2016
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
[ Thu, Dec 15th 2016
] - WOPRAI
Hartaj Singh Initiated (VRTX) at Hold on, Dec 15th, 2016
Hartaj Singh of Oppenheimer, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold on, Dec 15th, 2016.
Hartaj has made no other calls on VRTX in the last 4 months.
There are 5 other peers that have a rating on VRTX. Out of the 5 peers that are also analyzing VRTX, 4 agree with Hartaj's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Downgraded from Buy to Hold on, Tuesday, November 29th, 2016
- Debjit Chattopadhyay of "Janney Montgomery Scott" Initiated at Hold and Held Target at $98 on, Friday, November 18th, 2016
- Andrew Fein of "HC Wainwright & Co." Downgraded from Strong Buy to Hold on, Monday, October 24th, 2016
- Christopher Raymond of "Raymond James" Initiated at Hold on, Tuesday, September 13th, 2016
This is the rating of the analyst that currently disagrees with Hartaj
- Biren Amin of "Jefferies" Maintained at Strong Buy with Increased Target to $105 on, Wednesday, October 5th, 2016
